Display options
Share it on

Geneva Risk Insur Rev. 2020 Sep 22;1-29. doi: 10.1057/s10713-020-00054-z. Epub 2020 Sep 22.

Covid-19: implications for insurer risk management and the insurability of pandemic risk.

The Geneva risk and insurance review

Andreas Richter, Thomas C Wilson

Affiliations

  1. Ludwig-Maximilians-Universität München (LMU Munich), Munich, Germany.
  2. Present Address: Allianz Ayudhya, Bangkok, Thailand.

PMID: 32982612 PMCID: PMC7506824 DOI: 10.1057/s10713-020-00054-z

Abstract

This paper analyzes the insurability of pandemic risk and outlines how underwriting policies and scenario analysis are used to build resilience upfront and plan contingency actions for crisis scenarios. It then summarizes the unique "lessons learned" from the Covid-19 crisis by baselining actual developments against a reasonable, pre-Covid-19 pandemic scenario based on the 2002 SARS epidemic and 1918 Spanish influenza pandemic. Actual developments support the pre-Covid-19 hypothesis that financial market developments dominate claims losses due to the demographics of pandemics and other factors. However, Covid-19 "surprised" relative to the pre-Covid-19 scenario in terms of its impact on the real economy as well as on the property and casualty segment as business interruption property triggers and exclusions are challenged, something that may adversely impact the insurability of pandemics as well as the perception of the industry for some time to come. The unique lessons of Covid-19 reinforce the need for resilience upfront in solvency and liquidity, the need to improve business interruption wordings and re-underwrite the book, and the recognition that business interruption caused by pandemics may not be an insurable risk due to its large accumulation potential and the threat of external moral hazard. These insurability limitations lead to a discussion about the structure and financing of protection against the impact of future pandemics.

© The Author(s) 2020.

Keywords: Covid-19; Financial crisis; Insurability; Pandemic risk; Resiliency; Risk management

References

  1. Bull Hist Med. 1991 Spring;65(1):4-21 - PubMed
  2. Curr Biol. 2011 Dec 6;21(23):R941-5 - PubMed
  3. Emerg Infect Dis. 2006 Jan;12(1):15-22 - PubMed
  4. Am J Public Health. 2004 Apr;94(4):562-4 - PubMed
  5. Science. 1974 Sep 27;185(4157):1124-31 - PubMed
  6. Microbes Infect. 2020 Mar;22(2):69-71 - PubMed

Publication Types